1-4 of 4
Shridar Ganesan
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Pan-cancer Analysis of Homologous Recombination Repair–associated Gene Alterations and Genome-wide Loss-of-Heterozygosity Score

C. Benedikt Westphalen, Alexander D. Fine, Fabrice André, Shridar Ganesan, Volker Heinemann, Etienne Rouleau, Clare Turnbull, Luis Garcia Palacios, Jorge-Antonio Lopez, Ethan S. Sokol, Joaquin Mateo
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (7): 1412–1421.
https://doi.org/10.1158/1078-0432.CCR-21-2096
Published: 01 April 2022
View article titled, Pan-cancer Analysis of Homologous Recombination Repair–associated Gene Alterations and Genome-wide Loss-of-Heterozygosity Score
Open the PDF for Pan-cancer Analysis of Homologous Recombination Repair–associated Gene Alterations and Genome-wide Loss-of-Heterozygosity Score in another window
Includes: Supplementary data
Journal Articles

BRAF Fusion as a Novel Mechanism of Acquired Resistance to Vemurafenib in BRAFV600E Mutant Melanoma

Atul Kulkarni, Husam Al-Hraishawi, Srilatha Simhadri, Kim M. Hirshfield, Suzie Chen, Sharon Pine, Chandrika Jeyamohan, Levi Sokol, Siraj Ali, Man Lung Teo, Eileen White, Lorna Rodriguez-Rodriguez, Janice M. Mehnert, Shridar Ganesan
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2017) 23 (18): 5631–5638.
https://doi.org/10.1158/1078-0432.CCR-16-0758
Published: 14 September 2017
View article titled, <em>BRAF</em> Fusion as a Novel Mechanism of Acquired Resistance to Vemurafenib in <em>BRAF</em><sup>V600E</sup> Mutant Melanoma
Open the PDF for <em>BRAF</em> Fusion as a Novel Mechanism of Acquired Resistance to Vemurafenib in <em>BRAF</em><sup>V600E</sup> Mutant Melanoma in another window
Journal Articles

Abstract 08: Role of upfront genomic analysis of gastrointestinal stromal tumors to identify imatinib-insensitive or resistant cases

Aleksander Chojecki, Rebecca A. Moss, Hua Zhong, Elizabeth Poplin, Ellen Ronnen, Shridar Ganesan, Lorna Rodriguez Rodriguez, Kim M. Hirshfield
Journal: Clinical Cancer Research
Clin Cancer Res (2016) 22 (1_Supplement): 08.
https://doi.org/10.1158/1557-3265.PMSCLINGEN15-08
Published: 03 January 2016
View article titled, Abstract 08: Role of upfront genomic analysis of gastrointestinal stromal tumors to identify imatinib-insensitive or resistant cases
Journal Articles

Abstract B74: Elafin drives poor outcome in high-grade serous ovarian cancers and basal-like breast tumors

Intidhar Labidi-Galy, Adam Clauss, Vivian Ng, Sekhar Duraisamy, Kevin M. Elias, Erhan Bilal, Rachel A. Davidowitz, Yiling Lu, Gayane Badalian-Very, Hui-Ying Piao, Un-Beom Kang, Scott Ficarro, Shridar Ganesan, Gordon B. Mills, Jarrod Marto, Ronny Drapkin
Journal: Clinical Cancer Research
Clin Cancer Res (2013) 19 (19_Supplement): B74.
https://doi.org/10.1158/1078-0432.OVCA13-B74
Published: 13 May 2014
View article titled, Abstract B74: Elafin drives poor outcome in high-grade serous ovarian cancers and basal-like breast tumors